BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 7248957)

  • 1. Salvage of circulating pyrimidine nucleosides in the rat.
    Moyer JD; Oliver JT; Handschumacher RE
    Cancer Res; 1981 Aug; 41(8):3010-7. PubMed ID: 7248957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of N-(phosphonacetyl)-L-aspartate and pyrazofurin depletion of pyrimidine ribonucleotide and deoxyribonucleotide pools and their relationship to nucleic acid synthesis in intact and permeabilized cells.
    Moyer JD; Smith PA; Levy EJ; Handschumacher RE
    Cancer Res; 1982 Nov; 42(11):4525-31. PubMed ID: 7127293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibitors of the de novo pyrimidine biosynthetic pathway on serum uridine levels in mice.
    Karle JM; Anderson LW; Dietrick DD; Cysyk RL
    Cancer Res; 1981 Dec; 41(12 Pt 1):4952-5. PubMed ID: 6171344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage of circulating pyrimidine nucleosides by tissues of the mouse.
    Moyer JD; Malinowski N; Ayers O
    J Biol Chem; 1985 Mar; 260(5):2812-8. PubMed ID: 3972805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of pyrimidine synthesis and depletion of nucleotide pools by N-(phosphonacetyl)-L-aspartate.
    Moyer JD; Handschumacher RE
    Cancer Res; 1979 Aug; 39(8):3089-94. PubMed ID: 455293
    [No Abstract]   [Full Text] [Related]  

  • 7. Depletion of blood plasma cytidine due to increased hepatocellular salvage in D-galactosamine-treated rats.
    Holstege A; Manglitz D; Gerok W
    Eur J Biochem; 1984 Jun; 141(2):339-44. PubMed ID: 6734601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrimidine nucleosides enhance the efficacy of inhibitors of pyrimidine biosynthesis in cultured hepatocellular carcinoma cells.
    Jacobsen LB; Putnam JE; Sawick DP; Cassady JM; Morré DJ
    Life Sci; 1988; 42(8):913-8. PubMed ID: 3343891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of synergy between N-phosphonacetyl-L-aspartate and dipyridamole in a human ovarian carcinoma cell line.
    Chan TC; Howell SB
    Cancer Res; 1985 Aug; 45(8):3598-604. PubMed ID: 4016741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
    Karle JM; Cowan KH; Chisena CA; Cysyk RL
    Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspartate carbamoyltransferase activity, drug concentrations, and pyrimidine nucleotides in tissue from patients treated with N-(phosphonacetyl)-L-aspartate.
    Moore EC; Friedman J; Valdivieso M; Plunkett W; Marti JR; Russ J; Loo TL
    Biochem Pharmacol; 1982 Oct; 31(20):3317-21. PubMed ID: 7150358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uridine and cytidine metabolism following inhibition of de novo pyrimidine synthesis by pyrazofurin.
    Cadman E; Benz C
    Biochim Biophys Acta; 1980 Oct; 609(3):372-82. PubMed ID: 7437431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipyrimidine effects of five different pyrimidine de novo synthesis inhibitors in three head and neck cancer cell lines.
    Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2018; 37(6):329-339. PubMed ID: 29723133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of plasma concentrations of uridine on pyrimidine biosynthesis in cultured L1210 cells.
    Karle JM; Anderson LW; Cysyk RL
    J Biol Chem; 1984 Jan; 259(1):67-72. PubMed ID: 6323418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects with inhibitors of de novo pyrimidine synthesis, acivicin, and N-(phosphonacetyl)-L-aspartic acid.
    Loh E; Kufe DW
    Cancer Res; 1981 Sep; 41(9 Pt 1):3419-23. PubMed ID: 7260907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimidine salvage pathways in adult Schistosoma mansoni.
    el Kouni MH; Naguib FN
    Int J Parasitol; 1990 Feb; 20(1):37-44. PubMed ID: 2312224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrimidine salvage in Giardia lamblia.
    Aldritt SM; Tien P; Wang CC
    J Exp Med; 1985 Mar; 161(3):437-45. PubMed ID: 3973534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage of pyrimidine nucleosides by Trichomonas vaginalis.
    Wang CC; Cheng HW
    Mol Biochem Parasitol; 1984 Feb; 10(2):171-84. PubMed ID: 6199666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.